SkylineDx Holding B.V.

SkylineDx is a healthcare innovator specializing in molecular diagnostic tests that analyze gene expression to support personalized treatment decisions. They collaborate with academic and clinical partners to develop diagnostics across oncology and infectious diseases, aiming to bridge biomarker discoveries to commercial applications. Recognized for excellence, SkylineDx is committed to advancing value-based healthcare globally.